$Viatris Inc.(VTRS)$Viatris ($VTRS) Extremely Undervalued and Estimated 5% Dividend Yield Soon.Viatris is a new pharmaceutical stock formed from the combination of Mylan and the Upjohn division of Pfizer, released onto the Nasdaq in November.The company offers many well-known therapies (such as Xanax, Viagra, etc) which were originally part of Upjohn's collection of branded drugs.Below a brief summary of both the negatives and positives surrounding this stock, however if you want a better understanding I have left some articles below.Positives* The company plans to offer a dividend (estimated around 5% yield) using at least 25% of the company's free cash flow. This is a lot better than Pfizer's current yield of around 4.2%.* A dividend cut down the r